Powerful Medical Receives €40 Million IPCEI Grant — read the full story

PM Magazine

Doctor holding Roche cobas® pulse point-of-care device displaying PMcardio AI-powered ECG interpretation for real-time heart attack detection at the patient bedside.

PMcardio Expands Heart Attack Detection to Patient Bedside through Roche cobas® pulse Point of Care Platform

Powerful Medical has partnered with Roche to integrate AI-powered ECG interpretation from PMcardio into the cobas® pulse point-of-care platform. Combined with Roche’s Elecsys® high-sensitivity cardiac Troponin T assay, this solution enables clinicians to rapidly and accurately rule in or rule out heart attacks directly at the patient’s bedside.

Editor's Choice

Independent RCT and Late-Breaking Science: PMcardio to Take Center Stage at TCT 2025

6. October 2025
Powerful Medical awarded €40M IPCEI grant to expand AI diagnostics for heart attacks, heart failure, and arrhythmias

Powerful Medical Receives €40 Million Non-Dilutive Grant to Accelerate Early Diagnosis of Cardiovascular Diseases with AI

28. July 2025
Collage showing a conference speaker, PMcardio app UI, hospital partnerships across Europe, and a research award ceremony.

May Highlights from Powerful Medical: PMcardio 3.0 Launch, STEMI Research, and Clinical Breakthroughs

7. June 2025

Independent RCT and Late-Breaking Science: PMcardio to Take Center Stage at TCT 2025

We’re proud to share that PMcardio and the Queen of Hearts™ (STEMI AI ECG model) will be prominently featured at Transcatheter Cardiovascular Therapeutics (TCT) 2025, the largest interventional cardiology conference in the U.S., taking place October 25–27, 2025 in San Francisco, California.
Collage showing a conference speaker, PMcardio app UI, hospital partnerships across Europe, and a research award ceremony.

May Highlights from Powerful Medical: PMcardio 3.0 Launch, STEMI Research, and Clinical Breakthroughs

May was a milestone month at Powerful Medical. From launching PMcardio for Individuals 3.0 and showcasing new explainable AI tools, to advancing STEMI detection through international research and clinical collaboration—discover the breakthroughs that are shaping the future of cardiac care.

ECGxplain™: The Explainability Feature in PMcardio -With Human-Centered Design in Mind

In high-stakes emergency and cath lab settings, every second counts when diagnosing acute myocardial infarctions. PMcardio’s Explainability feature brings unmatched transparency to AI-powered ECG analysis, empowering clinicians with clear, trustworthy insights for faster, more confident decision-making.

Announcing the AI-ECG TIMI Study: A Multi-Center Validation

We are thrilled to announce the launch of the AI-ECG TIMI Study, a novel, international, multi-center observational study aimed at validating the use of AI to improve the detection and management of acute coronary syndromes (ACS).

Stay on the pulse with our newsletter

Your submission was successful